Clinical Trial Update: Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of Melasma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing two Tri-Luma maintenance regimens for melasma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Tri-Luma (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%)

Snippet

Sponsor: Galderma R&D | Conditions: Melasma | Phase 4 | Status: COMPLETED